Anti-inflammatory effect of resveratrol in old mice liver

Experimental Gerontology

Volumn 64, Issue , 2015, Pages 1-7

  Tung, Bui Thanh ^a,b,c   Rodríguez Bies, Elisabeth ^a   Talero, Elena ^b   Gamero Estévez, Enrique ^a   Motilva, Virginia ^b   Navas, Plácido ^a   López Lluch, Guillermo ^a  

^a Universidad Pablo de Olavide   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

Author keywords

Aging; Cytokines; Inflammation; Liver; Resveratrol

Indexed keywords

ASC PROTEIN; CYCLOOXYGENASE 2; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MEMBRANE PROTEIN; MESSENGER RNA; NALP 1 PROTEIN; NALP 3 PROTEIN; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEPATITIS; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; UPREGULATION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; INFLAMMATION; LIVER; METABOLISM; OXIDATIVE STRESS;

ANIMALIA; MUS; RICE STRIPE VIRUS;

AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOMARKERS; CYTOKINES; INFLAMMATION; LIVER; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; RNA, MESSENGER; STILBENES;

EID: 84922985477     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2015.02.004     Document Type: Article

References (45)

1. Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N., Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004, 20:319-325.
2. Aravinthan A., Shannon N., Heaney J., Hoare M., Marshall A., Alexander G.J. The senescent hepatocyte gene signature in chronic liver disease. Exp. Gerontol. 2014, 60C:37-45.
3. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., Hornung V., Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
4. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., De Cabo R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. Brenner C., Galluzzi L., Kepp O., Kroemer G. Decoding cell death signals in liver inflammation. J. Hepatol. 2013, 59:583-594.
7. Brüünsgaard H., Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol. Allergy Clin. N. Am. 2003, 23:15-39.
8. Bruunsgaard H., Skinhøj P., Pedersen A.N., Schroll M., Pedersen B.K. Ageing, tumour necrosis factor-alpha (TNF-α) and atherosclerosis. Clin. Exp. Immunol. 2000, 121:255-260.
9. Chung H.Y., Sung B., Jung K.J., Zou Y., Yu B.P. The molecular inflammatory process in aging. Antioxid. Redox Signal. 2006, 8:572-581.
10. Chung H.Y., Lee E.K., Choi Y.J., Kim J.M., Kim D.H., Zou Y., Kim C.H., Lee J., Kim H.S., Kim N.D., Jung J.H., Yu B.P. Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J. Dent. Res. 2011, 90:830-840.
11. de Vries J.E. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 1995, 27:537-541.
12. Di Iorio A., Ferrucci L., Sparvieri E., Cherubini A., Volpato S., Corsi A., Bonafè M., Franceschi C., Abate G., Paganelli R. Serum IL-1β levels in health and disease: a population-based study. 'The InCHIANTI study'. Cytokine 2003, 22:198-205.
13. Dobbs R.J., Charlett A., Purkiss A.G., Dobbs S.M., Weller C., Peterson D.W. Association of circulating TNF-alpha and IL-6 with ageing and Parkinsonism. Acta Neurol. Scand. 1999, 100:34-41.
14. Feng Y.H., Zhu Y.N., Liu J., Ren Y.X., Xu J.Y., Yang Y.F., Li X.Y., Zou J.P. Differential regulation of resveratrol on lipopolysacchride-stimulated human macrophages with or without IFN-γ pre-priming. Int. Immunopharmacol. 2004, 4:713-720.
15. Fu Y., Wang Y., Du L., Xu C., Cao J., Fan T., Liu J., Su X., Fan S., Liu Q., Fan F. Resveratrol inhibits ionising irradiation-induced inflammation in MSCs by activating SIRT1 and limiting NLRP-3 inflammasome activation. Int. J. Mol. Sci. 2013, 14:14105-14118.
16. Fulgenzi A., Bertelli A.A.E., Magni E., Ferrero E., Ferrero M.E. In vivo inhibition of TNFα-induced vascular permeability by resveratrol. Transplant. Proc. 2001, 33:2341-2343.
17. Gao X., Xu Y.X., Janakiraman N., Chapman R.A., Gautam S.C. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem. Pharmacol. 2001, 62:1299-1308.
18. Gee J.R., Ding Q., Keller J.N. Modulation of apolipoprotein E and interleukin-1β in the aging liver. Exp. Gerontol. 2005, 40:409-415.
19. Glasgow S.C., Ramachandran S., Blackwell T.S., Mohanakumar T., Chapman W.C. Interleukin-1β is the primary initiator of pulmonary inflammation following liver injury in mice. Am. J. Physiol. 2007, 293:L491-L496.
20. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
21. Huang T.T., Lai H.C., Chen Y.B., Chen L.G., Wu Y.H., Ko Y.F., Lu C.C., Chang C.J., Wu C.Y., Martel J., Ojcius D.M., Chong K.Y., Young J.D. cis-Resveratrol produces anti-inflammatory effects by inhibiting canonical and non-canonical inflammasomes in macrophages. Innate Immun. 2013, 10.1177/1753425913507096.
22. Jung K.J., Lee E.K., Yu B.P., Chung H.Y. Significance of protein tyrosine kinase/protein tyrosine phosphatase balance in the regulation of NF-kappaB signaling in the inflammatory process and aging. Free Radic. Biol. Med. 2009, 47:983-991.
23. Lanzilli G., Cottarelli A., Nicotera G., Guida S., Ravagnan G., Fuggetta M. Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 2012, 35:240-248.
24. Martinez J., Moreno J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 2000, 59:865-870.
25. Martinon F. Signaling by ROS drives inflammasome activation. Eur. J. Immunol. 2010, 40:616-619.
26. Martinon F., Pétrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
27. Rivera L., Morón R., Zarzuelo A., Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem. Pharmacol. 2009, 77:1053-1063.
28. Saiko P., Szakmary A., Jaeger W., Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Mutat. Res. Rev. Mutat. Res. 2008, 658:68-94.
29. Salminen A., Kaarniranta K., Kauppinen A. Inflammaging: disturbed interplay between autophagy and inflammasomes. Aging (Albany NY) 2012, 4:166-175.
30. Schmucker D.L. Aging and the liver: an update. J. Gerontol. A Biol. Sci. Med. Sci. 1998, 53A:B315-B321.
31. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger?. Science 2010, 327:296-300.
32. Schwabe R.F., Brenner D.A. Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways. Am. J. Physiol. 2006, 290:G583-G589.
33. Shakibaei M., Harikumar K.B., Aggarwal B.B. Resveratrol addiction: to die or not to die. Mol. Nutr. Food Res. 2009, 53:115-128.
34. Subbaramaiah K., Dannenberg A.J. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci. 2003, 24:96-102.
35. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 1998, 273:21875-21882.
36. Szabo G., Csak T. Inflammasomes in liver diseases. J. Hepatol. 2012, 57:642-654.
37. Szkudelska K., Szkudelski T. Resveratrol, obesity and diabetes. Eur. J. Pharmacol. 2010, 635:1-8.
38. Tung B.T., Rodriguez-Bies E., Ballesteros-Simarro M., Motilva V., Navas P., Lopez-Lluch G. Modulation of endogenous antioxidant activity by resveratrol and exercise in mouse liver is age dependent. J. Gerontol. A Biol. Sci. Med. Sci. 2013, 69:398-409.
39. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17:179-188.
40. Williams L.M., Lali F., Willetts K., Balague C., Godessart N., Brennan F., Feldmann M., Foxwell B.M.J. Rac mediates TNF-induced cytokine production via modulation of NF-κB. Mol. Immunol. 2008, 45:2446-2454.
41. Wunderlich F.T., Ströhle P., Könner A.C., Gruber S., Tovar S., Brönneke H.S., Juntti-Berggren L., Li L.-S., van Rooijen N., Libert C., Berggren P.-O., Brüning J.C. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab. 2010, 12:237-249.
42. Yang S.J., Lim Y. Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. Metabolism 2014, 63:693-701.
43. Ye Z., Ting J.P.-Y. NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr. Opin. Immunol. 2008, 20:3-9.
44. Zhong M., Cheng G.F., Wang W.J., Guo Y., Zhu X.Y., Zhang J.T. Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice. Phytomedicine 1999, 6:79-84.
45. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11:136-140.